Why pumps? Continuous subcutaneous insulin infusion for children and adolescents with type 1 diabetes

Isr Med Assoc J. 2004 May;6(5):271-5.


CSII is a feasible, safe and well-accepted mode of therapy for many children with type 1 diabetes. For a significant number of patients and parents, it serves as a much easier means of coping with the huge daily burden of diabetes. Therefore, we believe that both CSII and MDI should be made available to the diabetic team and the patients to better tailor therapy, improve satisfaction and decrease the fear of hypoglycemia.

Publication types

  • Review

MeSH terms

  • Adolescent
  • Child
  • Diabetes Mellitus, Type 1 / drug therapy*
  • Humans
  • Hypoglycemic Agents / administration & dosage*
  • Injections, Subcutaneous
  • Insulin / administration & dosage*
  • Insulin Infusion Systems* / adverse effects
  • Insulin Infusion Systems* / psychology
  • Patient Satisfaction


  • Hypoglycemic Agents
  • Insulin